HB907 • 2026

HEALTH CARE/PROVIDERS: Provides civil and criminal immunity for the distribution or use of Naloxone and other opioid antagonists beyond their shelf-life end date

Enacted

This bill passed the Legislature and reached final enactment based on the latest official action.

Sponsor: Dustin Miller
Last action: 2026-05-15
Official status: Signed by the Governor - Act 183
Effective date: Not listed

Plain English Breakdown

The candidate explanation includes claims about protecting individuals using Naloxone and ensuring protection against professional disciplinary actions which are not directly supported in the provided official bill text.

Health Care Providers Immunity for Naloxone and Opioid Antagonists

This act provides legal protection to health care providers who distribute or use Naloxone and other opioid antagonists past their expiration dates under certain conditions.

What This Bill Does

Gives doctors, pharmacists, and others who give out Naloxone or similar drugs immunity from being sued if the drug has passed its expiration date.

Who It Names or Affects

Health care providers like doctors and pharmacists who prescribe, dispense, distribute, or furnish Naloxone or other opioid antagonists.
People who use these drugs to help someone experiencing an opioid overdose.

Terms To Know

shelf-life end date: The date after which a drug is no longer guaranteed to be effective and safe according to federal regulations.

Limits and Unknowns

Federal rules still apply, so health care providers must follow them even if this law gives some protection.
This act only protects against civil and criminal liability; it does not cover professional disciplinary actions unless specified in the law.

Amendments

These notes stay tied to the official amendment files and metadata from the legislature.

House Committee Amendment #2416 H&W Adopted

Adopted

Plain English: HCAHB907 4921 2416 HOUSE COMMITTEE AMENDMENTS 2026 Regular Session Amendments proposed by House Committee on Health and Welfare to Original House Bill No.

HCAHB907 4921 2416 HOUSE COMMITTEE AMENDMENTS 2026 Regular Session Amendments proposed by House Committee on Health and Welfare to Original House Bill No.
907 by Representative Miller 1 AMENDMENT NO.
1 2 On page 2, line 3, change "Paragraphs" to "Subsections" Page 1 of 1 CODING: Words in struck through type are deletions from existing law; words underscored are additions.

House Committee Amendment #1478 H&W Draft

Draft

Plain English: HCAHB907 4921 1478 HOUSE COMMITTEE AMENDMENTS 2026 Regular Session Amendments proposed by House Committee on Health and Welfare to Original House Bill No.

HCAHB907 4921 1478 HOUSE COMMITTEE AMENDMENTS 2026 Regular Session Amendments proposed by House Committee on Health and Welfare to Original House Bill No.
907 by Representative Miller 1 AMENDMENT NO.
1 2 On page 2, line 3, change "Paragraphs" to "Subsections" Page 1 of 1 CODING: Words in struck through type are deletions from existing law; words underscored are additions.

Bill History

2026-05-15 H
Effective date: 05/15/2026.
2026-05-15 H
Signed by the Governor. Becomes Act No. 183.
2026-05-13 H
Sent to the Governor for executive approval.
2026-05-12 S
Signed by the President of the Senate.
2026-05-12 H
Enrolled and signed by the Speaker of the House.
2026-05-11 H
Received from the Senate without amendments.
2026-05-11 S
Read by title, passed by a vote of 35 yeas and 0 nays, and ordered returned to the House. Motion to reconsider tabled.
2026-04-28 S
Reported without Legislative Bureau amendments. Read by title and passed to third reading and final passage.
2026-04-27 S
Read by title and referred to the Legislative Bureau.
2026-04-22 S
Reported favorably.
2026-04-07 S
Read second time by title and referred to the Committee on Health and Welfare.
2026-04-01 S
Received in the Senate. Read first time by title and placed on the Calendar for a second reading.
2026-04-01 H
Read third time by title, roll called on final passage, yeas 96, nays 0. Finally passed, title adopted, ordered to the Senate.
2026-03-30 H
Scheduled for floor debate on 04/01/2026.
2026-03-26 H
Read by title, amended, ordered engrossed, passed to 3rd reading.
2026-03-25 H
Reported with amendments (10-0).
2026-03-09 H
Read by title, under the rules, referred to the Committee on Health and Welfare.
2026-02-27 H
First appeared in the Interim Calendar on 2/27/2026.
2026-02-27 H
Under the rules, provisionally referred to the Committee on Health and Welfare.
2026-02-27 H
Prefiled.

Official Summary Text

HEALTH CARE/PROVIDERS: Provides civil and criminal immunity for the distribution or use of Naloxone and other opioid antagonists beyond their shelf-life end date

Current Bill Text

Read the full stored bill text

ENROLLED
ACT No. 1832026 Regular Session
HOUSE BILL NO. 907
BY REPRESENTATIVE MILLER
1 AN ACT
2 To enact R.S. 40:978.2.3, relative to prescriptions; to provide for civil and criminal
3 immunity for the distribution or use of Naloxone and other opioid antagonists
4 beyond their shelf-life end date; and to provide for related matters.
5 Be it enacted by the Legislature of Louisiana:
6 Section 1. R.S. 40:978.2.3 is hereby enacted to read as follows:
7 §978.2.3. Naloxone; distribution or use after shelf-life end date; limitation of
8 liability
9 A. Notwithstanding any provision of law to the contrary, a person who
10 prescribes, dispenses, distributes, or furnishes naloxone or another opioid antagonist
11 shall not be subject to criminal or civil liability solely on the basis that any labeled
12 shelf-life end date for such product has passed.
13 B. Notwithstanding any provision of law to the contrary, a person acting in
14 good faith who furnishes or administers naloxone or another opioid antagonist,
15 including one for which any labeled shelf-life end date has passed, to an individual
16 reasonably believed to be undergoing an opioid-related drug overdose shall be
17 immune from criminal and civil liability for such furnishing or administration except
18 in the event of gross negligence or willful or wanton misconduct.
19 C. A licensed healthcare practitioner shall not be subject to disciplinary
20 action by a professional licensing board for any action for which the practitioner is
21 granted civil and criminal immunity under Subsections A and B of this Section.
Page 1 of 2
CODING: Words in struck through type are deletions from existing law; words underscored
are additions.
HB NO. 907 ENROLLED
1 D. As used in this Section, the term "shelf-life end date" means any labeled
2 date required by 21 CFR part 211.137 or any successor regulation.
3 E. Notwithstanding any provision of this Section, a federally certified health
4 care provider, facility, or entity shall comply with federal regulations and
5 requirements, including such regulations prohibiting the prescribing, dispensing,
6 distributing, furnishing, or administering drugs whose shelf-life end date has passed.
7 Section 2. This Act shall become effective upon signature by the Governor or, if not
8 signed by the Governor, upon expiration of the time for bills to become law without
9 signature by the Governor, as provided in Article III, Section 18 of the Constitution of
10 Louisiana. If vetoed by the Governor and subsequently approved by the Legislature, this Act
11 shall become effective on the day following such approval.
SPEAKER OF THE HOUSE OF REPRESENTATIVES
PRESIDENT OF THE SENATE
GOVERNOR OF THE STATE OF LOUISIANA
APPROVED:
Page 2 of 2
CODING: Words in struck through type are deletions from existing law; words underscored
are additions.